Buchumschlag

Extracorporeal haemoadsorption: does the evidence support its routine use in critical care?

Extracorporeal haemoadsorption is increasingly being used for the removal of endotoxin or inflammatory cytokines in patients with septic shock or other severe inflammatory states. A reduction in excessively high levels of inflammatory mediators—and mitigation of the devastating clinical impact of se...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Supady, Alexander (VerfasserIn) , Brodie, Daniel (VerfasserIn) , Wengenmayer, Tobias (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2022
In: The lancet. Respiratory medicine
Year: 2022, Jahrgang: 10, Heft: 3, Pages: 307-312
ISSN:2213-2619
DOI:10.1016/S2213-2600(21)00451-3
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/S2213-2600(21)00451-3
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2213260021004513
Volltext
Verfasserangaben:Alexander Supady, Daniel Brodie, Tobias Wengenmayer

MARC

LEADER 00000caa a2200000 c 4500
001 1797423304
003 DE-627
005 20220820160210.0
007 cr uuu---uuuuu
008 220404s2022 xx |||||o 00| ||eng c
024 7 |a 10.1016/S2213-2600(21)00451-3  |2 doi 
035 |a (DE-627)1797423304 
035 |a (DE-599)KXP1797423304 
035 |a (OCoLC)1341458097 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Supady, Alexander  |d 1981-  |e VerfasserIn  |0 (DE-588)139700897  |0 (DE-627)612710246  |0 (DE-576)312800924  |4 aut 
245 1 0 |a Extracorporeal haemoadsorption  |b does the evidence support its routine use in critical care?  |c Alexander Supady, Daniel Brodie, Tobias Wengenmayer 
264 1 |c 2022 
300 |a 6 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online December 15, 2021 
500 |a Gesehen am 05.04.2022 
520 |a Extracorporeal haemoadsorption is increasingly being used for the removal of endotoxin or inflammatory cytokines in patients with septic shock or other severe inflammatory states. A reduction in excessively high levels of inflammatory mediators—and mitigation of the devastating clinical impact of severe inflammation—might be a sound rationale for extracorporeal haemoadsorption in critical care, but the evidence for beneficial effects is uncertain. Few randomised controlled trials have been undertaken, and they have not provided reliable evidence for routine use in clinical practice. No study has shown a survival benefit, and only a few studies have shown a significant effect on patients' blood cytokine concentrations. Nonetheless, some clinicians have encouraged the use of haemoadsorption devices, largely on the basis of incomplete data or contentious interpretations of the available data. Further research is required, particularly well designed, prospective clinical trials assessing relevant patient-centred outcomes, including mortality, before widespread adoption of this technology can be recommended. 
700 1 |a Brodie, Daniel  |e VerfasserIn  |0 (DE-588)1254849831  |0 (DE-627)179763674X  |4 aut 
700 1 |a Wengenmayer, Tobias  |d 1977-  |e VerfasserIn  |0 (DE-588)129286907  |0 (DE-627)707201063  |0 (DE-576)29757972X  |4 aut 
773 0 8 |i Enthalten in  |t The lancet. Respiratory medicine  |d Oxford : Elsevier, 2013  |g 10(2022), 3, Seite 307-312  |w (DE-627)737292180  |w (DE-600)2704917-6  |w (DE-576)379472759  |x 2213-2619  |7 nnas  |a Extracorporeal haemoadsorption does the evidence support its routine use in critical care? 
773 1 8 |g volume:10  |g year:2022  |g number:3  |g pages:307-312  |g extent:6  |a Extracorporeal haemoadsorption does the evidence support its routine use in critical care? 
856 4 0 |u https://doi.org/10.1016/S2213-2600(21)00451-3  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S2213260021004513  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20220404 
993 |a Article 
994 |a 2022 
998 |g 139700897  |a Supady, Alexander  |m 139700897:Supady, Alexander  |d 910000  |d 912800  |e 910000PS139700897  |e 912800PS139700897  |k 0/910000/  |k 1/910000/912800/  |p 1  |x j 
999 |a KXP-PPN1797423304  |e 4111796257 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"given":"Alexander","family":"Supady","role":"aut","roleDisplay":"VerfasserIn","display":"Supady, Alexander"},{"given":"Daniel","family":"Brodie","role":"aut","roleDisplay":"VerfasserIn","display":"Brodie, Daniel"},{"roleDisplay":"VerfasserIn","display":"Wengenmayer, Tobias","role":"aut","family":"Wengenmayer","given":"Tobias"}],"title":[{"title_sort":"Extracorporeal haemoadsorption","subtitle":"does the evidence support its routine use in critical care?","title":"Extracorporeal haemoadsorption"}],"recId":"1797423304","language":["eng"],"note":["Published online December 15, 2021","Gesehen am 05.04.2022"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"name":{"displayForm":["Alexander Supady, Daniel Brodie, Tobias Wengenmayer"]},"id":{"eki":["1797423304"],"doi":["10.1016/S2213-2600(21)00451-3"]},"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"2022"}],"relHost":[{"id":{"issn":["2213-2619"],"eki":["737292180"],"zdb":["2704917-6"]},"origin":[{"dateIssuedDisp":"2013-","dateIssuedKey":"2013","publisher":"Elsevier","publisherPlace":"Oxford"}],"title":[{"partname":"Respiratory medicine","title_sort":"lancet","title":"The lancet"}],"part":{"issue":"3","pages":"307-312","year":"2022","extent":"6","text":"10(2022), 3, Seite 307-312","volume":"10"},"titleAlt":[{"title":"The lancet <London> / Respiratory medicine"}],"pubHistory":["1.2013 -"],"recId":"737292180","language":["eng"],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 01.04.14"],"disp":"Extracorporeal haemoadsorption does the evidence support its routine use in critical care?The lancet. Respiratory medicine"}],"physDesc":[{"extent":"6 S."}]} 
SRT |a SUPADYALEXEXTRACORPO2022 

Ähnliche Einträge